Walgreen's (NYSE:WAG) most recent earnings report shows a company that is still the envy of an industry from an operational standpoint, but suffering through a period of slow growth, uncertain prospects and tough comparisons.

IN PICTURES: 20 Tools For Building Up Your Portfolio

For its fiscal third quarter, the company posted $463 million in net income, or $0.47 per share, down 11% from a year ago. Total sales were up 6% year over year, to $17.2 billion, of which over 65% comes from prescription sales.

There were some charges pushing down on earnings in the third quarter, including four cents for the elimination of Medicare Part D subsidies and two cents for the acquisition of NY-based Duane Reade drug stores.

There was little to be excited about in the report, as evidenced by the 7% drop in Walgreen shares on Tuesday. To be fair, comparisons were tough versus one year ago, when H1N1 fears ruled the land and sent customers flocking to the drug store aisles. (For related reading, check out Measuring The Medicine Makers.)

Competition, Economy & Health Care Reform Loom
In the standalone field of retail drug stores, Walgreen still gets it done better than its peers. Gross margins were up year ago despite the weak economy, and stand at a healthy 27.6%, much better than rival CVS Caremark (NYSE:CVS) at 20%. Rite Aid (NYSE:RAD) looks like a similarly smooth operator with 26% gross margins, but the picture falls apart further down the income statement - Rite Aid has been posting net losses since way back when the economy was on solid footing.

The critical same-store sales measure is positive at Walgreen, but just barely. Pharmacy comps were up 0.7%, while "front-end" sales were up 0.1%. CVS grew pharmacy comps faster (3.7%) in their most recent quarter, but they have the benefit of the pharmacy benefits management (PBM) business to drive sales.

Meanwhile all the pharmacy companies - including burgeoning players like Wal-Mart (NYSE:WMT) and Costco (Nasdaq:COST) - complain of difficulties with pharmacy reimbursements, a trend that's certain to continue as healthcare reform shakes out in the coming quarters.

The Bottom Line
Walgreen shares have underperformed the S&P 500 by about 20% this year after closing out 2009 on a tear. While the drop is understandable given all the unknowns surrounding the industry -the stock market despises the unknown - Walgreen remains the top operator in the space. Their balance sheet is pristine, the stock sports a 2% yield, and prospects for the entire industry should perk up nicely in 2011 when a slew of new generics will hit the shelves.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  2. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  3. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  4. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  5. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  6. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  7. Professionals

    What to do During a Market Correction

    The market has corrected...now what? Here's what you should consider rather than panicking.
  8. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
  9. Mutual Funds & ETFs

    ETF Analysis: Schwab US Broad Market

    Take an in-depth look at the Schwab U.S. Broad Market ETF, an incredibly low-cost fund based on a wide selection of the U.S. equity market.
  10. Professionals

    Tips for Helping Clients Though Market Corrections

    When the stock market sees a steep drop, clients are bound to get anxious. Here are some tips for talking them off the ledge.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  5. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
  6. BHD (Berhad)

    The suffix Bhd. is an abbreviation of a Malay word "berhad," ...
RELATED FAQS
  1. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  2. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  3. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
  6. What happens to the shares of stock purchased in a tender offer?

    The shares of stock purchased in a tender offer become the property of the purchaser. From that point forward, the purchaser, ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!